Ultragenyx Pharmaceutical Inc.
RARE · Healthcare · $1.5B
$15.03-1.89%
Price
$33.47
$15.32
Jul 2, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$184M-14.1%
6/'26 vs prev quarter
Company Health
Market Cap$1.5B
Operating Margin-73.8%
Cash on Hand$292M19.7% of market cap
Free Cash Flow$-489M-33.1% of market cap
Among 327 Biotechnology peers
LowMedianHigh
PSR2.1xmedian 11.4xROE+206.5%median -54.5%
